UnknownNot Applicable

Analysis of Cardiac Biomarkers, ECG and CPET Results in Children With Cardiomyopathies

Poland80 participantsStarted 2020-03-01

Plain-language summary

The aim of the study is to analyze cardiac biomarkers, electrocardiograms and cardio-pulmonary exercise test (CPET) results in children with cardiomyopathies.

Who can participate

Age range1 Day – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children with HCM, DCM, LVNC diagnosed in 2D echo. * Healthy children with no congenital heart disease (CHD) in 2D echo. * Patients who signed consent form. Exclusion Criteria: * Patients with coexisting CHD, kidney and liver disfunction, taking anti-psychotic and anti-depressant medication, or patients with bundle bunch blocks in ECG. * no consent form signed.

What they're measuring

Assessment of ECG (electrocardiographic) differences in children with cardiomyopathies and healthy children.

Timeframe: 14 months

Assessment of differences in CPET results in children with cardiomyopathies and healthy children.

Timeframe: 14 months

Trial details

NCT IDNCT04316923

SponsorKatarzyna Łuczak-Woźniak

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03

View on ClinicalTrials.gov More Cardiomyopathies trials